Click here for Analysts' Upgrades, Downgrades.Editor's Note: Green and red arrows refer to intraday stock price movement. NEW YORK ( TheStreet) -- AmerisourceBergen ( ABC) added to Conviction Buy List at Goldman. Company has good earnings visibility over the next couple of years. Agco ( AGCO) estimates, target upped at Goldman. AGCO estimates were boosted through 2012. Visibility is improving for demand in Western Europe. Buy rating and new $55 price target. Allegiant Travel ( ALGT) price target cut at Barclays to $59 from $61. Investing in ALGT is risky, outlook uncertain, Barclays said. Maintain Overweight rating. Applied Materials ( AMAT) target, estimates higher at Credit Suisse. AMAT price target raised by a dollar to $15. Strong sector view, Credit Suisse said. 2010 and 2011 EPS estimates raised to $0.87 and $1.25, respectively. Maintain Neutral rating. Darden Restaurants ( DRI) target boosted at Oppenheimer to $57. Company is likely seeing higher sales, especially at Red Lobster. Edwards Lifesciences ( EW) price target higher at Barclays to $80 from $75. Building out commercial infrastructure ahead of the potentially significant Sapien launch, Barclays said. Maintain Overweight rating. Health Management Associates ( HMA) price target boosted at Barclays by a dollar to $11. HMA has shown continued signs of progress with better-than-expected revenue growth, Barclays said. Maintain Overweight rating. US Airways Group ( LCC) price target raised at Barclays by a dollar to $15. Supply and demand balance in the industry will improve in the coming years, Barclays said. Maintain Equal Weight rating. Novellus Systems ( NVLS) target, estimate boosted at Barclays to $43 from $35 on stronger growth, Credit Suisse said. 2011 and 2012 EPS estimates increased to $3.56 and $3.69, respectively. Maintain Outperform rating. Occidental Petroleum ( OXY) target increased at Oppenheimer. OXY target was raised to $105, Oppenheimer said. Company recently boosted its dividend and should continue to generate steady cash flow. Pioneer Natural ( PXD) target raised at Oppenheimer. Shares of PXD now seen reaching $96, according to Oppenheimer. Company can continue to outperform its peers, despite lower energy prices. Tesoro ( TSO) price target raised at Barclays. TSO price target increased to $20 from $16 after positive meeting with management, Barclays said. Maintain Equal Weight rating.